NCT04477798 is a NA clinical trial of PCT-DIA/MS in Thyroid Nodule, sponsored by Luo Dingcun.

Who is sponsoring NCT04477798?

NCT04477798 is sponsored by Luo Dingcun.

What drugs are being tested in NCT04477798?

Interventions in NCT04477798: PCT-DIA/MS.

What condition does NCT04477798 study?

NCT04477798 studies Thyroid Nodule.

Is NCT04477798 still recruiting?

NCT04477798 is currently status unknown. Last updated 20 July 2020.

Last reviewed 2020-07-20 · How we verify

NCT04477798

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Protein Classifier for Thyroid Indeterminate Nodules

Status unknown NA Last updated 20 July 2020

What this trial tests

NA trial testing PCT-DIA/MS in Thyroid Nodule in 320 participants. Status unknown.

Timeline

1 August 2020

Primary endpoint
1 July 2021

31 December 2021

Quick facts

Lead sponsor	Luo Dingcun
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	diagnostic
Enrollment	320
Start date	1 August 2020
Primary completion	1 July 2021
Estimated completion	31 December 2021
Sites	1 location across China

Drugs / interventions tested

PCT-DIA/MS

Conditions studied

Thyroid Nodule — all drugs for Thyroid Nodule →

Sponsor

Luo Dingcun

Who can join

Adults 18 to 70, any sex, with Thyroid Nodule. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

In multi-center, prospective, double-blind cohorts, PCT-DIA/MS protein classifier supported by artificial neural networks will be validated to classify thyroid indeterminate nodules.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Thyroid Nodule

Currently open trials in the same condition.

NCT07428057 — Postoperative Hypocalcemia After Thyroidectomy · recruiting
NCT07488325 — Multimodal Assessment of Malignancy in Atypia of Undetermined Significance in Thyroid Nodules Using Ultrasound and Cytol · recruiting
NCT07370675 — Active Surveillance for Bethesda IV Thyroid Nodules · NA · recruiting
NCT07287176 — Prospective Evaluation of the Pulse Biosciences nPulse™ Vybrance™ Percutaneous Electrode System · NA · recruiting
NCT06730321 — Surgical Competency for Robot-Assisted Thyroidectomy: Construction and Validation of a Robotic Thyroidectomy Assessment · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04477798 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Luo Dingcun
Last refreshed: 20 July 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04477798.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing